<SEC-DOCUMENT>0001437749-16-043858.txt : 20161228
<SEC-HEADER>0001437749-16-043858.hdr.sgml : 20161228
<ACCEPTANCE-DATETIME>20161228164908
ACCESSION NUMBER:		0001437749-16-043858
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20161227
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161228
DATE AS OF CHANGE:		20161228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		162072947

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		7323591100

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi20161228_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD><TITLE>bkyi20161228_8k.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA1 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>UNITED STATES </B></FONT></P>
<P id=PARA2 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P id=PARA3 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Washington, D.C. 20549</B></FONT></P>
<HR style="BORDER-TOP: medium none; HEIGHT: 1px; BORDER-RIGHT: medium none; WIDTH: 10%; BORDER-BOTTOM: medium none; COLOR: #000000; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000" align=center>

<P id=PARA4 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B></B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FORM 8-K</B></FONT></P>
<P id=PARA7 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA8 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CURRENT REPORT </B></FONT></P>
<P id=PARA9 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 </B></FONT></P>
<P id=PARA10 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA11 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Date of Report (Date of earliest event reported): December 27, 2016 </FONT></P>
<P id=PARA12 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA13 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-KEY INTERNATIONAL, INC.</B></FONT></P>
<P id=PARA14 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Exact name of registrant as specified in its charter) </FONT></P>
<P id=PARA15 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL22  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA16 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Delaware</B></FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA17 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>001-13463</B></FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA18 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>41-1741861</B></FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA19 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(State or other jurisdiction of incorporation)</FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA20 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Commission File Number)</FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA21 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(I.R.S. Employer Identification No.)</FONT></P></TD></TR></TABLE>
<P id=PARA23 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA24 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>3349 Highway 138, Building A, Suite E</B></FONT></P>
<P id=PARA25 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Wall, NJ 07719 </B></FONT></P>
<P id=PARA26 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Address of principal executive offices) (Zip Code) </FONT></P>
<P id=PARA27 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA28 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(732) 359-1100</B></FONT></P>
<P id=PARA29 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Registrant's telephone number, including area code) </FONT></P>
<P id=PARA30 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA31 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<U>see</U><I> </I>General Instruction A.2. below):</FONT></P>
<P id=PARA32 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA33 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P id=PARA34 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA35 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
<P id=PARA36 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA37 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
<P id=PARA38 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA39 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9744;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
<P id=PARA40.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK40  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR40  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM40  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR40  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA40.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA42 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 5.03&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendments to Articles of Incorporation of Bylaws; Change in Fiscal Year.</B></FONT></P>
<P id=PARA43 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA44 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As previously reported in BIO-key International, Inc.&#8217;s (the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) Current Report on Form 8-K, on January 27, 2016, the Company&#8217;s stockholders approved an amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock in the range of 1-for-4 to 1-for-12, </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">with the final decision of whether to proceed with the reverse stock split and the exact ratio and timing of the reverse split to be determined by our board of directors (the &#8220;Board&#8221;), in its discretion, no later than December 30, 2016.</FONT></P>
<P id=PARA45 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA46 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On December 12, 2016, our Board set the reverse split ratio at 1-for-12 and on December 27, 2016, we filed a Certificate of Amendment to effect the reverse stock split. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and is incorporated by reference herein. Our common stock will begin trading on the OTCQB on a split-adjusted basis on December 29, 2016 under a new CUSIP number 09060C309. Our ticker symbol will temporarily be appended with &#8220;D&#8221; to signify the effectiveness of the reverse split for a period of 20 days.</FONT></P>
<P id=PARA47 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA48 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At the effective time of the 1-for-12 reverse stock split, every 12 shares of issued and outstanding common stock will be converted into 1 share of issued and outstanding stock, and the total outstanding shares of common stock will be reduced from approximately 73.1 million to approximately 6.1 million. The number of authorized shares and the par value per share will remain unchanged. No fractional shares will be issued in connection with the reverse stock split.&nbsp;Any fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.&nbsp;It is not necessary for stockholders to exchange their existing stock certificates for new stock certificates in connection with the reverse stock split.&nbsp;Stockholders who hold their shares in brokerage accounts or "street name" are also not required to take any action to effect the exchange of their shares.</FONT></P>
<P id=PARA49 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA50 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Events</B></FONT></P>
<P id=PARA51 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA52 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On December 28, 2016, we issued a press release announcing the effectiveness of the reverse split, a copy of which is attached hereto as Exhibit 99.1 and incorporated by reference herein.</FONT></P>
<P id=PARA53 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA54 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></FONT></P>
<P id=PARA55 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA56 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certificate of Amendment </FONT></P>
<P id=PARA57 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release dated December 28, 2016</FONT></P>
<P style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA58.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK58  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR58  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM58  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: left">2</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR58  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA58.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA59 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SIGNATURES</B></FONT></P>
<P id=PARA60 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA61 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P id=PARA62 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL73  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD vAlign=top width="50%">
<P id=PARA73.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="38%" colSpan=2>
<P id=PARA73.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIO-Key International, Inc.</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA73.3 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA73.4 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA73.5 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA73.6 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA73.7 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA73.8 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA73.9 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width="35%" noWrap align=left>
<P id=PARA73.10 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA73.11 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="TEXT-ALIGN: left" vAlign=top width="50%" align=left>
<P id=PARA73.12 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>Date: December 28, 2016</P></TD>
<TD style="TEXT-ALIGN: left" vAlign=top width="3%">
<P id=PARA73.13 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By: </FONT></P></TD>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=top width="35%" noWrap align=left>
<P id=PARA73.14 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/&nbsp;</FONT>Cecilia C. Welch</P></TD>
<TD vAlign=top width="12%">
<P id=PARA73.15 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA73.16 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA73.17 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA73.18 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">Cecilia C. Welch</P></TD>
<TD vAlign=top width="12%">
<P id=PARA73.19 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA73.20 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA73.21 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA73.22 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief Financial Officer </FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA73.23 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR></TABLE>
<P id=PARA65 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">3</P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML><HEAD><TITLE>ex3-1.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA39 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exhibit 3.1</B></FONT></P>
<P id=PARA40 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: left; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA1 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CERTIFICATE OF AMENDMENT</B></FONT></P>
<P id=PARA2 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>TO THE</B></FONT></P>
<P id=PARA3 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CERTIFICATE OF INCORPORATION</B></FONT></P>
<P id=PARA4 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>OF</B></FONT></P>
<P id=PARA5 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-KEY INTERNATIONAL, INC.</B></FONT></P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________</FONT></P>
<P id=PARA7 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Pursuant to Section 242 of the</B></FONT></P>
<P id=PARA8 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>General Corporation Law of the State of Delaware</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA9 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">________________</FONT></P>
<P id=PARA10 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA12 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BIO-key International, Inc., a Delaware corporation (the &#8220;<I><B>Corporation</B></I>&#8221;), does hereby certify as follows: </FONT></P>
<P id=PARA13 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA14 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">FIRST: Upon the filing and effectiveness (the &#8220;<I><B>Effective Time</B></I>&#8221;) pursuant to the General Corporation Law of the State of Delaware (the &#8220;<I><B>DGCL</B></I>&#8221;) of this Certificate of Amendment to the Certificate of Incorporation of the Corporation, each twelve (12) shares of the Corporation&#8217;s common stock, par value $0.0001 per share (the &#8220;<I><B>Common Stock</B></I>&#8221;), issued and outstanding or held by the Corporation in treasury stock immediately prior to the Effective Time shall automatically be combined into one (1)&nbsp;validly issued, fully paid and non-assessable share of Common Stock without any further action by the Corporation or the holder thereof, subject to the treatment of fractional interests as described below. Notwithstanding the immediately preceding sentence, no fractional shares will be issued in connection with the reverse stock split. Stockholders of record who otherwise would be entitled to receive fractional shares, will be entitled to rounding up of their fractional share to the nearest whole share. No stockholder will receive cash in lieu of fractional shares. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (the &#8220;<I><B>Old Certificates</B></I>&#8221;) shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the adjustment for fractional shares as described above.</FONT></P>
<P id=PARA15 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA16 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following paragraphs shall be inserted at the end of Article FOURTH:</FONT></P>
<P id=PARA17 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA18 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Upon the filing and effectiveness (the &#8220;<I><B>Effective Time</B></I>&#8221;) pursuant to the General Corporation Law of the State of Delaware (the &#8220;<I><B>DGCL</B></I>&#8221;) of this Certificate of Amendment to the Certificate of Incorporation of the Corporation, each twelve (12) shares of the Corporation&#8217;s common stock, par value $0.0001 per share (the &#8220;<I><B>Common Stock</B></I>&#8221;), issued and outstanding or held by the Corporation in treasury stock immediately prior to the Effective Time shall automatically be combined into one (1)&nbsp;validly issued, fully paid and non-assessable share of Common Stock without any further action by the Corporation or the holder thereof, subject to the treatment of fractional interests as described below. Notwithstanding the immediately preceding sentence, no fractional shares will be issued in connection with the reverse stock split. Stockholders of record who otherwise would be entitled to receive fractional shares, will be entitled to rounding up of their fractional share to the nearest whole share. No stockholder will receive cash in lieu of fractional shares. Each certificate that immediately prior to the Effective Time represented shares of Common Stock (the &#8220;<I><B>Old Certificates</B></I>&#8221;) shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the adjustment for fractional shares as described above.</FONT></P>
<P id=PARA41.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK41  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR41  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM41  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR41  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA41.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA20 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">SECOND: The foregoing amendment was duly adopted in accordance with Section 242 of the DGCL. </FONT></P>
<P id=PARA21 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA22 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">THIRD: This Certificate of Amendment shall become effective upon filing.</FONT></P>
<P id=PARA23 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA24 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>[signature page follows]</I></FONT></P>
<P id=PARA25 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>&nbsp;</I></FONT></P>
<P id=PARA42.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK42  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR42  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM42  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR42  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA42.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA26 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its undersigned officer this 27<SUP style="vertical-align: baseline; position: relative; bottom:.33em;">th</SUP> day of December, 2016. </FONT></P>
<P id=PARA27 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL43  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD vAlign=top width="50%">
<P id=PARA43.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="38%" colSpan=2>
<P id=PARA43.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIO-KEY INTERNATIONAL, INC. </FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA43.3 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA43.4 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA43.5 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA43.6 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA43.7 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA43.8 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA43.9 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=bottom width="35%" noWrap align=left>
<P id=PARA43.10 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="12%">
<P id=PARA43.11 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD style="TEXT-ALIGN: left" vAlign=top width="50%" align=left>
<P id=PARA43.12 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD style="TEXT-ALIGN: left" vAlign=top width="3%">
<P id=PARA43.13 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By: </FONT></P></TD>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=top width="35%" noWrap align=left>
<P id=PARA43.14 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/&nbsp;</FONT><I>Michael W. DePasquale</I></P></TD>
<TD vAlign=top width="12%">
<P id=PARA43.15 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA43.16 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA43.17 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA43.18 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>Michael W. DePasquale</P></TD>
<TD vAlign=top width="12%">
<P id=PARA43.19 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR>
<TR>
<TD vAlign=top width="50%">
<P id=PARA43.20 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="3%">
<P id=PARA43.21 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD>
<TD vAlign=top width="35%">
<P id=PARA43.22 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>Chief Executive Officer</P></TD>
<TD vAlign=top width="12%">
<P id=PARA43.23 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P></TD></TR></TABLE>
<P id=PARA31 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 225pt">&nbsp;</P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD><TITLE>ex99-1.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA36 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exhibit 99.1</B></FONT></P>
<P id=PARA37 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: left; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P><IMG src="logo001.jpg" width=382 height=107>
<P id=PARA3 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA5 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Seeking to Position its Shares for Nasdaq Uplisting, Biometric ID Provider</B></FONT></P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-key to Effect 1</B><B>-for-1</B><B>2</B><B> Reverse Stock Sp</B><B>lit</B></FONT></P>
<P id=PARA7 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><I>&nbsp;</I></FONT></P>
<P id=PARA8 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Wall, NJ, </B><B>December 28,</B><B> 2016</B> &#8211; BIO-key International, Inc. (</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>OTCQB: BKYI</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">), a trusted provider of enterprise and consumer biometric software and hardware authentication solutions, announced that its Board of Directors has approved a 1-for-12 reverse split of the Company's common stock. The reverse stock split, which was approved by shareholders earlier this year, is intended to increase the average share price of BIO-key&#8217;s common stock, in support of the Company&#8217;s plans to seek uplisting to The Nasdaq Capital Market. BIO-key has filed a listing application with Nasdaq and plans to pursue such listing as soon as it is able to meet all initial listing criteria, particularly the $3.00 minimum bid price requirement.</FONT></P>
<P id=PARA9 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA10 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Trading of the Company's common stock on the OTCQB Market will continue, on a post-split basis, with the opening of markets on Thursday, December 29, 2016, under the temporary trading symbol "BKYID" and under the new CUSIP number 09060C309. The trading symbol would revert to "BKYI" after 20 business days.</FONT></P>
<P id=PARA11 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA12 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Every twelve (12) shares held will be combined into one (1) new share of BIO-key common stock. In lieu of fractional shares, shareholders will receive a rounded up new share of BIO-key Common stock. Except for those with pre-split share ownership of eleven shares or fewer, shareholders&#8217; percentage ownership in the Company will remain virtually unchanged as a result of the reverse split. Pro rata adjustments will also be made to BIO-key's restricted stock, convertible preferred stock, warrants and stock option programs.</FONT></P>
<P id=PARA13 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA14 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Following completion of the reverse split, BIO-key&#8217;s common shares issued and outstanding will be reduced to approximately 6.1 million (from approximately 73.1 million) and the Company&#8217;s adjusted common shares outstanding, giving effect to the conversion of the Company&#8217;s convertible preferred stock, will be approximately 11.5 million. BIO-key&#8217;s total authorized shares remain 170 million following the reverse split. </FONT></P>
<P id=PARA15 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA16 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mike DePasquale, BIO-key Chairman and CEO said, "Having secured shareholder approval at the beginning of the year, we are excited to execute the reverse split which is a major step in our efforts to uplist our common stock on The Nasdaq Capital Market. We believe that the reverse split will also provide the Company with renewed flexibility with respect to funding our growth or using our equity to pursue synergistic M&amp;A activity.</FONT></P>
<P id=PARA17 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA18 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">While we cannot be certain of the outcome of our uplisting process, the Board believes BIO-key&#8217;s visibility, long term goals and corporate brand are far better served both by a higher share price and the potential for a higher profile listing on Nasdaq. We believe these factors will help expand the potential pool of investors who would be able to consider an investment in BIO-key, while also supporting the growing visibility of our software and hardware products and the BIO-key brand.&#8221;</FONT></P>
<P id=PARA19 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA38.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK38  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR38  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM38  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR38  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA38.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA20 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To support its investor visibility and uplisting efforts, BIO-key has retained the services of Maxim Group LLC, a New York-based investment bank.</FONT></P>
<P id=PARA21 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA22 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>About BIO-key </B>(</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>www.bio-key.com</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)<B> </B></FONT></P>
<P id=PARA23 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.95pt 0pt 18.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BIO-key is revolutionizing authentication as our easy-to-use biometric solutions enable convenient and secure access to information and financial transactions. We eliminate passwords, PINs, tokens and cards and make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium finger scanning devices </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SideTouch</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">, </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SideSwipe</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> and </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>EcoID</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> offer market-leading quality, performance and price. </FONT></P>
<P id=PARA24 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.95pt 0pt 18.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA25 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.95pt 0pt 18.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>About Maxim Group LLC</B></FONT></P>
<P id=PARA26 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.95pt 0pt 18.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Maxim Group LLC is a leading full service banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking, private wealth management; and global institutional equity, fixed income and derivative sales and trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals, Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA). Securities Insurance Protection Corporation (SIPC), NASDAQ Stock market and NYSE Arca, Inc. To learn more about Maxim Group, visit www.maximgrp.com.</FONT></P>
<P id=PARA27 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA28 style="TEXT-ALIGN: left; MARGIN: 0pt 17.95pt 0pt 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-key Safe Harbor Statement </B></FONT></P>
<P id=PARA29 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.95pt 0pt 18.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, market acceptance of biometric solutions generally and our specific offerings, our ability to expand into the Asian market, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made.</FONT></P>
<P id=PARA30 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA31 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA32 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Investor &amp; Media Contacts: </B></FONT></P>
<P id=PARA33 style="TEXT-ALIGN: justify; MARGIN: 0pt 17.6pt 0pt 17.75pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.5pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David Collins, William Jones</FONT></P>
<P id=PARA34 style="TEXT-ALIGN: left; MARGIN: 0pt 69.7% 0pt 18pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Catalyst Global<BR>212-924- 9800 </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>bkyi@catalyst-ir.com</B></FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </FONT></P>
<P id=PARA35 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo001.jpg
<TEXT>
begin 644 logo001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MNB1PFK_!KP;JENR1:<;"7'RRVKE2I^AR#^5>.ZKIOB7X,>*XI[&Z,EI,<QR
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MW/@ 'H".._:N6TOXEV/B'P[9ZEI\G]GF>]BMRM];2D-O<J%4@ %F X(R!WH
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
